Endurance Athletes Researching NAD+ — Performance Data

A 2023 study published in Cell Metabolism found that endurance athletes supplementing with nicotinamide riboside (NR), an NAD+ precursor, increased skeletal muscle NAD+ levels by 60% while simultaneously improving VO2 max by 2.1%. A margin that separates podium finishes from mid-pack results in competitive endurance sport. The mechanism isn't stimulant-based energy. It's mitochondrial biogenesis, the process by which cells generate new energy-producing mitochondria in response to metabolic demand.

We've worked with researchers examining NAD+ protocols across multiple endurance disciplines. The gap between theoretical benefit and measurable outcome comes down to dosing, timing, and understanding what NAD+ actually does at the cellular level versus what supplement marketing claims it does.

What is NAD+ and why does it matter for endurance performance?

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell that facilitates electron transfer in the mitochondrial respiratory chain. The process that converts glucose and oxygen into ATP, the energy currency cells use. In endurance athletes researching NAD+, the primary interest is mitochondrial density and efficiency: more mitochondria per muscle fiber means greater oxidative capacity, which translates to higher sustainable power output before crossing the lactate threshold.

Most endurance athletes researching NAD+ assume it functions like a pre-workout stimulant. It doesn't. NAD+ levels don't spike energy immediately; they enable the cellular infrastructure that produces sustained aerobic energy over weeks of consistent supplementation. The rest of this piece covers the specific pathways NAD+ activates, evidence-based dosing protocols for endurance athletes, what preparation mistakes negate absorption entirely, and why timing matters more than most athletes realize.

The Mitochondrial Efficiency Mechanism Behind NAD+ in Endurance Sport

NAD+ drives performance improvement through AMPK (AMP-activated protein kinase) activation and SIRT1 (sirtuin 1) upregulation. Two metabolic pathways that together stimulate mitochondrial biogenesis and improve fat oxidation efficiency. AMPK functions as a cellular energy sensor: when ATP levels drop during sustained aerobic effort, AMPK triggers PGC-1α (peroxisome proliferator-activated receptor gamma coactivator 1-alpha), the master regulator of mitochondrial production. SIRT1, an NAD+-dependent deacetylase enzyme, enhances this process by improving mitochondrial quality control. Removing damaged mitochondria through mitophagy while simultaneously increasing the synthesis of new, functional mitochondria.

For endurance athletes researching NAD+, this matters because mitochondrial density directly determines oxidative capacity. A trained cyclist with higher mitochondrial density can sustain 280 watts for 60 minutes while a less-adapted athlete might hold that power for 12 minutes before lactate accumulation forces a reduction in output. NAD+ precursor supplementation. Primarily nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). Has been shown in clinical trials to increase skeletal muscle mitochondrial content by 9–14% after 8–12 weeks of consistent dosing.

The fat oxidation component is equally significant. Endurance athletes researching NAD+ often overlook that improved NAD+ availability shifts substrate utilization away from glycogen toward fatty acids during submaximal effort. Research conducted at the University of Colorado found that trained runners supplementing with 1000mg NR daily increased their fat oxidation rate at 65% VO2 max by 18% compared to baseline. This allows glycogen stores to be preserved for higher-intensity efforts later in competition.

NAD+ Precursors: NR vs NMN and Bioavailability Differences

Nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) are the two most researched NAD+ precursors, but they follow different metabolic pathways to ultimately raise intracellular NAD+ levels. NR enters cells directly through nucleoside transporters and is then converted to NMN inside the cell before final conversion to NAD+. NMN, conversely, must first be dephosphorylated to NR outside the cell by the enzyme CD73 before it can enter. This extra step historically suggested NR would have superior bioavailability, though recent evidence complicates that assumption.

A 2024 pharmacokinetic study published in Nature Metabolism found that oral NMN supplementation (900mg) increased plasma NAD+ levels by 38% within 90 minutes, suggesting some NMN may enter circulation intact via a Slc12a8 transporter mechanism identified in the small intestine. NR, meanwhile, has been shown to raise whole-blood NAD+ levels by 40–90% depending on dosing and individual variation in NAD+ salvage pathway enzyme activity.

For endurance athletes researching NAD+, practical differences emerge in dosing and timing. NR has more robust human trial data at doses of 300–1000mg daily, typically split into morning and pre-training administration. NMN protocols studied range from 250mg to 900mg daily, though most published endurance performance data used 500–600mg as a single morning dose. Both compounds are heat-sensitive and degrade rapidly in solution. Sublingual NMN formulations marketed for faster absorption often degrade before reaching systemic circulation, making capsule forms preferable despite slower onset.

Our team has found that athletes focusing on mitochondrial adaptation during base-building phases respond well to consistent daily NR dosing (500–1000mg), while those seeking acute recovery support during high-volume training blocks sometimes report better subjective recovery with NMN dosed immediately post-training. The evidence for either protocol producing meaningfully different outcomes is limited. Consistency matters more than compound selection.

NAD+ Supplementation Protocols and Dosing for Endurance Athletes

Clinical trials examining NAD+ precursors in trained athletes have used daily doses ranging from 300mg to 2000mg, with the majority of performance-related benefits observed at 500–1000mg daily. A 2022 randomized controlled trial in the Journal of the International Society of Sports Nutrition tested 1000mg NR daily in competitive cyclists over 8 weeks and found significant improvements in time-to-exhaustion at 80% VO2 max (mean increase of 14.2%) compared to placebo. The same study showed no additional benefit when dosing was increased to 2000mg daily, suggesting a ceiling effect around 1000mg for most athletes.

Timing matters more than most endurance athletes researching NAD+ initially assume. NAD+ levels follow a circadian rhythm, peaking in the early morning and declining throughout the day. This rhythm is driven by NAMPT (nicotinamide phosphoribosyltransferase), the rate-limiting enzyme in the NAD+ salvage pathway, which is under circadian control. For this reason, morning dosing (6–8 AM) aligns with the body's natural NAD+ synthesis window and appears to produce more consistent plasma NAD+ elevation than evening dosing.

Pre-training dosing (30–60 minutes before endurance sessions) has shown mixed results in the literature. While NAD+ doesn't function as an acute ergogenic aid like caffeine, some athletes report improved substrate availability during long aerobic sessions when NR or NMN is taken 45 minutes pre-ride or pre-run. The mechanism here likely relates to improved fatty acid oxidation rather than direct energy provision.

Cycling NAD+ supplementation. One common question among endurance athletes researching NAD+. Is not supported by current evidence. Unlike stimulants that require periodic breaks to prevent receptor downregulation, NAD+ biosynthesis pathways do not exhibit tolerance. Continuous supplementation maintains elevated tissue NAD+ levels, while cessation results in a return to baseline within 2–3 weeks.

NAD+ and Performance: [Research-Grade Peptides] Comparison

For endurance athletes researching NAD+ who are also exploring peptide-based performance tools, understanding where NAD+ fits in the broader metabolic toolkit matters. NAD+ supplementation addresses the foundational energy metabolism layer. It doesn't replace anabolic signaling (GH secretagogues) or tissue repair pathways (BPC-157, TB-500), but it creates a more efficient mitochondrial environment that amplifies training adaptations driven by those other compounds.

Key Takeaways

• NAD+ precursors (NR and NMN) increase skeletal muscle NAD+ levels by 40–60%, driving mitochondrial biogenesis through AMPK and SIRT1 pathway activation. The mechanism is cellular infrastructure improvement, not acute energy provision.
• Endurance athletes researching NAD+ should target 500–1000mg daily dosing, split into morning and pre-training administration, with measurable VO2 max improvements typically emerging after 8–12 weeks of consistent supplementation.
• NR has more extensive human trial data at doses of 300–1000mg daily, while NMN shows comparable plasma NAD+ elevation at 500–900mg daily. Practical differences are minimal when dosing and timing are consistent.
• NAD+ improves fat oxidation efficiency at submaximal intensities (60–70% VO2 max) by 14–18%, preserving glycogen stores for higher-intensity efforts later in competition or training sessions.
• Cycling or periodizing NAD+ supplementation is unnecessary. NAD+ biosynthesis pathways do not exhibit tolerance, and continuous supplementation maintains elevated tissue NAD+ without diminishing returns.
• Stacking NAD+ precursors with peptides targeting anabolic signaling, recovery, or mitochondrial function (such as Real Peptides' Energy Mitochondria Fatigue Bundle) addresses both upstream substrate availability and downstream signaling pathways, amplifying training-induced mitochondrial adaptations.

What If: Endurance Athletes Researching NAD+ Scenarios

What If I Don't Notice Any Subjective Energy Increase After Two Weeks of NAD+ Supplementation?

Continue supplementing. NAD+ adaptation timelines are 6–8 weeks minimum. NAD+ precursors do not produce acute stimulant-like effects; the mechanism is mitochondrial biogenesis, which requires consistent training stimulus alongside supplementation to manifest as measurable performance improvement. Athletes expecting immediate energy boosts often discontinue before the adaptation window closes. Mitochondrial density changes and VO2 max improvements consistently appear after 8–12 weeks in clinical trials, not 2 weeks.

What If I'm Already Taking CoQ10 or Resveratrol — Should I Still Add NAD+ Precursors?

Yes. These compounds target overlapping but distinct pathways and show additive effects. CoQ10 functions within the electron transport chain as a mobile electron carrier between Complex I/II and Complex III, while NAD+ drives the upstream reactions that feed electrons into the chain at Complex I. Resveratrol activates SIRT1 independently of NAD+ but requires NAD+ as a cofactor for SIRT1 enzymatic activity. Supplementing both raises baseline NAD+ availability while simultaneously upregulating the enzyme that uses it. Research from the Buck Institute found that combining resveratrol (150mg) with NR (500mg) produced greater mitochondrial density improvements than either compound alone.

What If I Miss Several Days of NAD+ Supplementation During a Travel Block or Taper Week?

Resume normal dosing without loading or doubling doses. Tissue NAD+ levels decline gradually over 7–14 days after cessation. A 3–5 day gap does not erase prior adaptation. The mitochondrial biogenesis you've built through 8–12 weeks of consistent supplementation is driven by training-induced PGC-1α signaling as much as NAD+ availability, so a short interruption does not reverse mitochondrial density gains. Missing a single week may reduce plasma NAD+ by 15–25%, but tissue-level mitochondrial NAD+ remains elevated longer than blood markers suggest.

What If I'm Considering Stacking NAD+ with MOTS-c or Other Mitochondrial-Targeted Peptides?

This combination addresses both NAD+ substrate availability and direct mitochondrial signaling. Potentially additive for endurance athletes researching NAD+ who want to maximize oxidative capacity. MOTS-c is a mitochondrial-derived peptide that activates AMPK directly and has shown 12–18% improvements in endurance running capacity in preclinical models. When combined with NAD+ precursors, which also activate AMPK but through upstream SIRT1 pathways, the dual mechanism may amplify mitochondrial biogenesis beyond what either compound achieves alone. Dosing MOTS-c at 5–10mg subcutaneously 2–3 times weekly alongside 500–1000mg daily NR or NMN is the protocol we've observed most frequently among athletes experimenting with this stack.

The Realistic Truth About NAD+ for Endurance Performance

Here's the honest answer: NAD+ supplementation is not a shortcut to elite endurance performance, and it won't override poor training structure or inadequate recovery. The evidence supports measurable but modest improvements. 2–4% gains in VO2 max, 12–18% improvements in fat oxidation efficiency, 9–14% increases in mitochondrial density. But those gains are conditional. They require consistent dosing for 8–12 weeks minimum, structured training that provides sufficient stimulus for mitochondrial adaptation, and adequate caloric and protein intake to support the cellular remodeling NAD+ enables.

The supplement industry markets NAD+ as a longevity miracle and anti-aging breakthrough. Those claims extrapolate preclinical rodent data into human marketing copy without the evidence to support it. What we know from human trials is this: NAD+ precursors improve mitochondrial function in a dose-dependent manner, and mitochondrial function is the rate-limiting factor in aerobic performance. That's the extent of the claim endurance athletes researching NAD+ should care about.

If you're expecting NAD+ to feel like a pre-workout stimulant or deliver instant power increases, you'll be disappointed. If you're willing to commit to 12 weeks of consistent supplementation while training intelligently, the data supports meaningful oxidative capacity improvements that compound over time.

The information in this article is for educational and research purposes. Supplementation decisions should be made in consultation with a qualified sports medicine physician or licensed nutritionist familiar with your training load and health history.

For endurance athletes researching NAD+ who want to explore synergistic metabolic tools beyond NAD+ precursors alone, the precision and purity of research-grade peptides matter. Small-batch synthesis with exact amino-acid sequencing ensures consistency across batches. Critical when you're titrating doses over months of training cycles. You can explore high-purity research peptides designed for cutting-edge metabolic research at Real Peptides, where every compound is crafted with lab reliability as the standard.